Six UAB teams are finalists in the 2011-12 Alabama Launchpad class.

The therapy uses very low electromagnetic frequencies without medications or chemotherapy and showed significant results in a phase II study.
Published in Focus on Patient Care

A drug long used for adults with sickle cell disease could change how the disease is managed in very young children.

Page 2 of 2
Back to Top